Target intelligence / Profile preview

Solute carrier family 25 member 3 pseudogene 1 (SLC25A3P1)

Target: SLC25A3P1
Molecular classification: Pseudogene, Other (not a transporter, enzyme, receptor, or ion channel)

Overview

Solute carrier family 25 member 3 pseudogene 1 (SLC25A3P1) is a human pseudogene located on chromosome 1[6]. It shares sequence homology with functional members of the mitochondrial solute carrier family (SLC25), specifically SLC25A3, which operates as a phosphate carrier in mitochondria. Unlike its parent gene, SLC25A3P1 does not encode a functional protein and is not homologous to sodium/potassium/calcium exchangers (solute carrier family 24). SLC25A3P1 therefore does not serve known biological, receptor, transporter, or catalytic activities, nor is it implicated as a therapeutic target or disease biomarker[1][2][6].

Other names: Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 pseudogene 1SLC25A3P1FLJ40434Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 pseudogene 1 (appears to be a mistaken alias; SLC25A3P1 is not related to the SLC24 family)

Mechanism of action

Null (not targeted by drugs)

Biological functions

None confirmed (no protein product; does not participate in canonical functions such as transport, signaling, or enzymatic reactions)

Disease associations

None established (pseudogenes rarely play direct roles in disease as molecular targets)

Safety considerations

Null (not a therapeutic target)

Interacting drugs

None (no drugs target this molecule directly)

Biomarkers

Null (not used as a biomarker for disease or therapeutic response)

Beyond the preview

Go deeper on Solute carrier family 25 member 3 pseudogene 1 (SLC25A3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 3 pseudogene 1 (SLC25A3P1).

Explore the full profile